What is the current intraday price and volume for NOVN.SW stock?

NOVN.SW stock is trading at **CHF 108.50** intraday (06 Jan 2026) with volume **3,220,892**, above the average **2,844,784**, confirming heavy activity on the SIX trading session.

How is Novartis valued versus peers for NOVN.SW stock?

Novartis trades at a trailing PE of **18.84**, below the healthcare sector average PE of **32.55**. That gap suggests relative value but requires consideration of growth, pipeline and Sandoz margin dynamics.

What short-term forecast does Meyka AI give for NOVN.SW stock?

Meyka AI's forecast model projects **CHF 113.03** for the next month, implying a **+4.18%** upside versus **CHF 108.50**. Forecasts are model-based projections and not guarantees.

What are the main risks investors should watch for NOVN.SW stock?

Key risks for NOVN.SW stock include generic competition, regulatory or trial setbacks, FX fluctuations, and Sandoz execution. Any negative surprise in the 04 Feb 2026 results could pressure the stock.

CH Stocks

NOVN.SW stock CHF 108.50 on 06 Jan 2026 intraday: Most active on SIX, catalysts ahead

ByHuzaifa Zahoor January 6, 2026January 6, 2026

NOVN.SW stock is trading at CHF 108.50 intraday on 06 Jan 2026 and ranks among the SIX’s most active names by volume. We see a modest intraday pullback of -1.00% with 3,220,892 shares traded versus an average of 2,844,784. The move tracks broad healthcare action but also reacts to firm valuation and upcoming catalysts, including an earnings release scheduled for 04 Feb 2026. Below we break down price action, valuation, technicals, and model forecasts to show what active traders and longer-term investors should watch today.